We also generated RBM4 knockout ESCC cells using CRISPR-Cas9 system, and applied two siRNAs to knockdown RBM4 in ESCC cells (Supplementary 2a, b), which were subsequently subjected to morphological observation and SA-β-gal staining assays. This evidence concerns the gene RBM4 and esophageal squamous cell carcinoma.